ATLANTA (Reuters) - Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could ...

An experimental ablation therapy system that freezes heart tissue with a balloon catheter to treat a common heart rhythm disorder is far more effective than drug therapy, a study found Monday. Researchers compared the safety and efficacy of the Arctic Front CryoAblation Catheter System produced by US firm Medtronic to drug therapy over at least one year in 245 patients ...

Shares of Amylin Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information on its potential diabetes treatment. Amylin, along with partners Eli Lilly & Co. and Alkermes Inc., were not asked to conduct additional studies on the much anticipated drug exenatide LAR, or ...

BioSante Pharmaceuticals has received orphan drug status for its potential pancreatic cancer treatment, the company said Monday. The company said the Food and Drug Administration designation applied to its GVAX Pancreas Vaccine, which is undergoing clinical trials with other anticancer agents for safety, survival and response rates. The GVAX Pancreas Vaccine ...